Homoharringtonine overcomes the negative impact of genetic patterns on venetoclax plus azacitidine regimen in relapsed/refractory acute myeloid leukemia: a multi-center, cohort study
Asciminib provides better efficacy and favorable safety and tolerability vainvestigators-selected tyrosine kinase inhibitors(lS TKl) in newly diagnosed chronimyeloid leukemia(CML):results from the east Asia subgroup analysis of the pivotalASC4First study